Evidence map›Paper›PMID 26762335›Full record

ReviewHeart failure reviews2016

Sudden cardiac death in heart failure with preserved ejection fraction: a target for therapy?

Muthiah Vaduganathan, Ravi B Patel, Sanjiv J Shah, Javed Butler

Abstract readReview
PubMed Publisher
In one paragraph

Review in Heart failure reviews, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Epidemiology of heart failure with preserved ejection fraction.Nature reviews. Cardiology · 2017 · on this map
    Review
  7. Management of Arrhythmias in Heart Failure.Journal of cardiovascular development and disease · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Muthiah VaduganathanBrigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, 75 Francis St, Boston, MA, 02115, USA. muthu@md.northwestern.edu.
Ravi B PatelBrigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, 75 Francis St, Boston, MA, 02115, USA.
Sanjiv J ShahNorthwestern University Feinberg School of Medicine, Chicago, IL, USA.
Javed ButlerDivision of Cardiology, Stony Brook University, Stony Brook, NY, USA.
Brigham and Women's Hospital · USHarvard University · USNorthwestern University · USStony Brook University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The incidence and mechanisms of sudden cardiac death (SCD) among patients with heart failure with reduced ejection fraction have been well characterized. Conversely, limited data are available exploring the landscape of SCD in patients with heart failure with preserved ejection fraction (HFpEF). HFpEF is a heterogeneous clinical syndrome of increasing prevalence and is associated with substantial morbidity and mortality. This review will aim to contextualize recent data regarding rates and predictors of SCD in this growing population and to discuss the potential role of pharmacologic and device therapy for prevention of SCD within the at-risk HFpEF subset.

Indexed as

Stroke VolumeVentricular Dysfunction, LeftCardiac Resynchronization TherapyCause of DeathDeath, Sudden, CardiacDefibrillators, ImplantableHeart FailureHumansIncidencePrognosisRisk AssessmentRisk FactorsArrhythmiasHeart failure with preserved ejection fractionSudden cardiac death

Identifiers

PMID26762335
OpenAlexW2238758462

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.